Literature DB >> 15172459

Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation.

Antonio Colombo, Ioannis Iakovou.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15172459     DOI： 10.1016/j.ehj.2004.04.004

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Drug eluting stents.

Authors:  A H Gershlick; G Richardson
Journal:  BMJ       Date:  2006-12-16

2.  Patient with recent coronary artery stent requiring major non cardiac surgery.

Authors:  Usha Kiran; Neeti Makhija
Journal:  Indian J Anaesth       Date:  2009-10

3.  Intravascular magnetic resonance/radiofrequency may enhance gene therapy for prevention of in-stent neointimal hyperplasia.

Authors:  Fabao Gao; Bensheng Qiu; Sourav Kar; Xiangcan Zhan; Lawrence V Hofmann; Xiaoming Yang
Journal:  Acad Radiol       Date:  2006-04       Impact factor: 3.173

4.  Physician factors as an indicator of technological device adoption.

Authors:  LaToya C Artis; Theresa M Burkhart; Tricia J Johnson; Karl A Matuszewski
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.920

5.  Novel nanostructured biomaterials: implications for coronary stent thrombosis.

Authors:  Varvara Karagkiozaki; Panagiotis G Karagiannidis; Nikolaos Kalfagiannis; Paraskevi Kavatzikidou; Panagiotis Patsalas; Despoina Georgiou; Stergios Logothetidis
Journal:  Int J Nanomedicine       Date:  2012-12-17

Review 6.  Drug eluting stents: focus on Cypher sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions.

Authors:  Alaide Chieffo; Tiziana Claudia Aranzulla; Antonio Colombo
Journal:  Vasc Health Risk Manag       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.